EG17255A - Esters of aryloxypropanolamine derivatives - Google Patents
Esters of aryloxypropanolamine derivativesInfo
- Publication number
- EG17255A EG17255A EG670/82A EG67082A EG17255A EG 17255 A EG17255 A EG 17255A EG 670/82 A EG670/82 A EG 670/82A EG 67082 A EG67082 A EG 67082A EG 17255 A EG17255 A EG 17255A
- Authority
- EG
- Egypt
- Prior art keywords
- esters
- aryloxypropanolamine derivatives
- aryloxypropanolamine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/14—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32077281A | 1981-11-12 | 1981-11-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
EG17255A true EG17255A (en) | 1990-08-30 |
Family
ID=23247810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG670/82A EG17255A (en) | 1981-11-12 | 1982-11-13 | Esters of aryloxypropanolamine derivatives |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0093155B1 (fr) |
JP (1) | JPS58501725A (fr) |
AU (1) | AU555517B2 (fr) |
CA (1) | CA1201437A (fr) |
DE (1) | DE3272925D1 (fr) |
EG (1) | EG17255A (fr) |
ES (2) | ES8401012A1 (fr) |
GR (1) | GR78295B (fr) |
IL (1) | IL67242A0 (fr) |
IT (1) | IT1149117B (fr) |
NZ (1) | NZ202229A (fr) |
WO (1) | WO1983001772A1 (fr) |
ZA (1) | ZA827646B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56108B1 (en) * | 1982-07-16 | 1991-04-24 | Carpibem | 1-(2-carbalkoxy-4-(thienylcarboxamido)phenoxy)-3-amino 2-propanols,their preparation and applications thereof in therapeutics |
US4508725A (en) * | 1982-12-22 | 1985-04-02 | American Hospital Supply Corporation | Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives |
US5334601A (en) * | 1984-03-14 | 1994-08-02 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
US4829086A (en) * | 1984-03-14 | 1989-05-09 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
US5202347A (en) * | 1984-03-14 | 1993-04-13 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
US5135926A (en) * | 1984-03-14 | 1992-08-04 | Bodor Nicholas S | Soft β-adrenergic blocking agents |
US4593039A (en) * | 1984-04-02 | 1986-06-03 | Merck & Co., Inc. | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols |
US4605513A (en) * | 1984-08-08 | 1986-08-12 | Eli Lilly And Company | Process for inhibiting peptide carbamylation |
AU2061588A (en) * | 1987-09-07 | 1989-03-09 | Imperial Chemical Industries Plc | Phenol ester of xamoterol |
US5229412A (en) * | 1988-03-25 | 1993-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Method for relieving anxiety using 5-hydroxytryptamine-1a-receptor-binding compounds |
US4935422A (en) * | 1988-12-15 | 1990-06-19 | E. I. Du Pont De Nemours And Company | Acyloxypropanolamines |
CA2015730C (fr) * | 1989-05-12 | 1997-10-07 | Sadahiko Iguchi | Esters de l'acide phenylalcanoique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2132570B1 (fr) * | 1971-04-09 | 1974-08-02 | Lipha | |
US3729477A (en) * | 1971-09-09 | 1973-04-24 | Frosst & Co Charles E | Certain 4-(3-amino-2-hydroxypropoxy)-1,2,5-thiadiazole-3-carboxamides |
US4083992A (en) * | 1972-12-15 | 1978-04-11 | Imperial Chemical Industries Limited | Alkanolamine derivatives |
-
1982
- 1982-10-19 ZA ZA827646A patent/ZA827646B/xx unknown
- 1982-10-20 NZ NZ202229A patent/NZ202229A/en unknown
- 1982-10-28 AU AU10407/83A patent/AU555517B2/en not_active Ceased
- 1982-10-28 JP JP58500056A patent/JPS58501725A/ja active Pending
- 1982-10-28 WO PCT/US1982/001537 patent/WO1983001772A1/fr active IP Right Grant
- 1982-10-28 EP EP82903622A patent/EP0093155B1/fr not_active Expired
- 1982-10-28 DE DE8282903622T patent/DE3272925D1/de not_active Expired
- 1982-11-10 GR GR69774A patent/GR78295B/el unknown
- 1982-11-10 CA CA000415312A patent/CA1201437A/fr not_active Expired
- 1982-11-11 ES ES517295A patent/ES8401012A1/es not_active Expired
- 1982-11-12 IL IL67242A patent/IL67242A0/xx not_active IP Right Cessation
- 1982-11-12 IT IT49476/82A patent/IT1149117B/it active
- 1982-11-13 EG EG670/82A patent/EG17255A/xx active
-
1983
- 1983-07-05 ES ES523878A patent/ES523878A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ZA827646B (en) | 1983-08-31 |
IT1149117B (it) | 1986-12-03 |
ES8500884A1 (es) | 1984-11-01 |
CA1201437A (fr) | 1986-03-04 |
IT8249476A0 (it) | 1982-11-12 |
GR78295B (fr) | 1984-09-26 |
JPS58501725A (ja) | 1983-10-13 |
NZ202229A (en) | 1985-11-08 |
IL67242A0 (en) | 1983-03-31 |
AU555517B2 (en) | 1986-09-25 |
ES517295A0 (es) | 1983-12-01 |
WO1983001772A1 (fr) | 1983-05-26 |
EP0093155A1 (fr) | 1983-11-09 |
EP0093155B1 (fr) | 1986-08-27 |
EP0093155A4 (fr) | 1984-04-24 |
DE3272925D1 (en) | 1986-10-02 |
ES8401012A1 (es) | 1983-12-01 |
ES523878A0 (es) | 1984-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU552609B2 (en) | Inner ester derivatives of gangliosides | |
DE3265843D1 (en) | Process for the preparation of carbonate esters | |
EG17255A (en) | Esters of aryloxypropanolamine derivatives | |
GB8415092D0 (en) | Ester derivatives | |
GB2151629B (en) | Apovincaminic acid ester derivatives | |
JPS57134474A (en) | Manufacture of lactone | |
ZA826927B (en) | Preparation of nitrite esters | |
JPS57192378A (en) | Manufacture of furan derivative | |
JPS57154180A (en) | Manufacture of furan derivatives | |
JPS57212158A (en) | Manufacture of s-arylthioglycolic acids | |
ZA826339B (en) | Ester derivatives of n-arylsulfinyl-n-phosphonomethylglycinates | |
DE3161608D1 (en) | Derivatives of phenoxy-phenoxy-carboxylic acids | |
ZA826338B (en) | Ester derivatives of n-arylsufinyl-n-phosphonomethylglycinonitrile | |
GB2101122B (en) | Purification of sucrose esters | |
ZA827270B (en) | Thiosulfenamide derivatives of n-phosphonomethylglycinonitriles | |
DE3264312D1 (en) | Process for the preparation of n-formyl-alpha-amino-acid esters | |
DE3265855D1 (en) | The preparation of derivatives of dichloroacetic acid esters | |
IL66413A0 (en) | Preparation of alpha-hydroxyphophonic acid esters | |
GB8504116D0 (en) | Preparation of acid esters | |
JPS57134434A (en) | Synthesis of 3-keto-cyclopentene-5-oxy derivatives | |
GB8314001D0 (en) | Preparation of alphahaloalkyl esters | |
EP0158957A3 (en) | Allophanic-acid ester derivatives | |
JPS56115746A (en) | Hydroxyaminomethyl derivatives of benzoylldiisubstituteddalphaaphenoxyalkanoyl esters | |
JPS57169461A (en) | Phenoxypyridylmethyl esters | |
GB2110665B (en) | Preparation of aminocyclopentanealkenoic acids |